4 completed, 3 recruiting, 2 terminated, 1 withdrawn. 10 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 4, Recruiting 3, Terminated 2, Withdrawn 1 |
| Phase 3 | 2 | Recruiting 2 |
Follow Joint Pain: new trials by email Literature Review of Joint Pain trials Research Report on Joint Pain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study of Hydroxychloroquine for the Treatment of AIMSS Hydroxychloroquine Sulfate (HCQ) - Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Joint Pain | Phase 2 | Recruiting | Indiana University | 35 | 2026-10-19 | 2026-11-10 |
| The MUSE Study for Menopausal Arthralgia Menopausal hormone therapy, Exercise training, Menopausal hormone therapy + exercise training - Arthralgia, Menopause | Phase 2 / Phase 3 | Recruiting | National University Hospital, Singapore | 100 | 2024-08-01 | 2024-07-31 |
| Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare Dapansutrile, Placebo Tablet - Acute Gout Flare, Gout Attack | Phase 2 / Phase 3 | Recruiting | Olatec Therapeutics, Inc. | 300 | 2023-01-06 | 2026-03-11 |
| Comparison Between Retrolaminar and Medial Branch Block in Cervical Facet Joint Arthropathy Retrolaminar block, Medial Branch Block - Joint Pain | Phase 2 | Completed | Mansoura University | 70 | 2021-12-01 | 2024-03-04 |
| Effects of Exten(d) Supplementation on Training Ability in Recreational Runners Polyherbal Exten(d) vs Placebo - Joint Pain, Knee Inflammation | Phase 2 | Completed | Natural Origins | 33 | 2018-09-10 | 2019-11-04 |
| Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer Women without Arthralgia, Women with Arthralgia - Breast Cancer, Arthralgia | Phase 2 | Withdrawn | Baylor Breast Care Center | 2013-10-01 | 2013-02-12 | |
| Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors Vitamin D3 - Muscle Pain, Joint Pain | Phase 2 | Completed | HealthPartners Institute | 116 | 2012-03-01 | 2019-06-18 |
| A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis Oxycodone CR (standard pain medication), JNJ-42160443, Placebo - Osteoarthritis, Osteoarthritis, Knee | Phase 2 | Terminated | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 196 | 2010-04-20 | 2020-03-11 |
| A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain JNJ-42160443, Placebo - Osteoarthritis, Osteoarthritis, Hip | Phase 2 | Terminated | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 467 | 2009-09-16 | 2020-03-11 |
| Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer Chondroitin, Glucosamine - Breast Cancer, Joint Pain | Phase 2 | Completed | Dawn L. Hershman | 53 | 2008-10-01 | 2022-11-08 |
Arthralgia (10) · Breast Neoplasms (3) · Inflammation (2) · Osteoarthritis (2) · Osteoarthritis, Knee (2) · Pain (2) · Arthritis (1) · Arthritis, Gouty (1) · Gout (1) · Hyperuricemia (1) · Motor Activity (1) · Myalgia (1) · Osteoarthritis, Hip (1)
Joint Diseases (10) · Musculoskeletal Diseases (10) · Neurologic Manifestations (10) · Pathological Conditions, Signs and Symptoms (10) · Signs and Symptoms (10) · Pain (8) · Breast Diseases (3) · Neoplasms (3) · Neoplasms by Site (3) · Rheumatic Diseases (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Arthritis (2) · Pathologic Processes (2) · Behavior (1)
fulranumab (2) · Aromatase Inhibitors (1) · Cholecalciferol (1) · Chondroitin (1) · Chondroitin Sulfates (1) · Exercise (1) · Glucosamine (1) · Hormone Replacement Therapy (1) · Hydroxychloroquine (1) · dapansutrile (1)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Baylor Breast Care Center (1) · Dawn L. Hershman (1) · HealthPartners Institute (1) · Indiana University (1) · Mansoura University (1) · National University Hospital, Singapore (1) · Natural Origins (1) · Olatec Therapeutics, Inc. (1)
United States (6) · Canada (2) · Spain (2) · Egypt (1) · France (1) · Israel (1) · Netherlands (1) · Poland (1) · Singapore (1) · South Korea (1)
Alice C. Shapiro, PhD RD (1) · Dawn Hershman, MD (1) · Marcela Gonzalez-Gross, phD (1) · Polly Niravath, MD (1) · Tarah Ballinger, MD (1)
PMID 26868123, PMID 27238963, PMID 27748055, PMID 34067240
2009 (2), 2023 (1)